Recent News

• 06.12.2025 - Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
• 06.12.2025 - Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
• 06.12.2025 - Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
• 06.09.2025 - Bridging the translational gap: The role of organoids in oncology R&D
• 06.05.2025 - William Blair 45th Annual Growth Stock Conference
• 06.05.2025 - William Blair 45th Annual Growth Stock Conference
• 06.02.2025 - Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
• 06.02.2025 - Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
• 06.02.2025 - Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
• 06.01.2025 - Introducing Tempus One in the EHR with Integrated Guidelines

Recent Filings

• 06.11.2025 - 144 Report of proposed sale of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 144 Report of proposed sale of securities